T2 Biosystems receives FDA 510(k) clearance for an expanded T2Bacteria Panel, including detection of Acinetobacter baumannii for bloodstream infections.

T2 Biosystems recently acquired FDA 510(k) clearance, expanding its T2Bacteria Panel to allow for the detection of Acinetobacter baumannii, a bacterial species causing bloodstream infections, particularly in critically ill patients. The new panel includes the detection of six sepsis-causing pathogens, enhancing the T2Bacteria Panel's efficiency for detecting sepsis-causing pathogens.

February 12, 2024
7 Articles